{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:57:06Z","timestamp":1794715026498,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Emerging data indicate that variations in quantitative epithelial and stromal tissue composition and their relative abundance in benign breast biopsies independently impact risk of future invasive breast cancer. To gain further insights into breast cancer etiopathogenesis, we investigated associations between epidemiological factors and quantitative tissue composition metrics of the normal breast.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study participants were 4108 healthy women ages 18\u201375\u00a0years who voluntarily donated breast tissue to the US-based Susan G. Komen Tissue Bank (KTB; 2008\u20132019). Using high-accuracy machine learning algorithms, we quantified the percentage of epithelial, stromal, adipose, and fibroglandular tissue, as well as the proportion of fibroglandular tissue that is epithelium relative to stroma (i.e., epithelium-to-stroma proportion, ESP) on digitized hematoxylin and eosin (H&amp;E)-stained normal breast biopsy specimens. Data on epidemiological factors were obtained from participants using a detailed questionnaire administered at the time of tissue donation. Associations between\u00a0epidemiological factors and square root transformed tissue metrics were investigated using multivariable linear regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      With increasing age, the amount of stromal, epithelial, and fibroglandular tissue declined and adipose tissue increased, while that of ESP demonstrated a bimodal pattern. Several epidemiological factors were associated with individual tissue composition metrics, impacting ESP as a result. Compared with premenopausal women, postmenopausal women had lower ESP [\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (95% Confidence Interval (CI))\u2009=\u2009\u22120.28 (\u2212\u20090.43,\u2009\u2212\u20090.13);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001] with ESP peaks at 30\u201340\u00a0years and 60\u201370\u00a0years among pre- and postmenopausal women, respectively. Pregnancy [\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (95%CI)\n                      <jats:sub>vs nulligravid<\/jats:sub>\n                      \u2009=\u20090.19 (0.08, 0.30);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001] and increasing number of live births (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>-trend<\/jats:sub>\n                      \u2009&lt;\u20090.001) were positively associated with ESP, while breastfeeding was inversely associated with ESP [\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (95%CI)\n                      <jats:sub>vs no breastfeeding<\/jats:sub>\n                      \u2009=\u2009\u22120.15 (\u2212\u20090.29,\u2009\u2212\u20090.01);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.036]. A positive family history of breast cancer (FHBC) [\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (95%CI)\n                      <jats:sub>vs no FHBC<\/jats:sub>\n                      \u2009=\u20090.14 (0.02\u20130.26);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02], being overweight or obese [\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (95%CI)\n                      <jats:sub>vs normal weight<\/jats:sub>\n                      \u2009=\u20090.18 (0.06\u20130.30);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004 and 0.32 (0.21\u20130.44);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively], and Black race [\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (95%CI)\n                      <jats:sub>vs White<\/jats:sub>\n                      \u2009=\u20090.12 (\u2212\u20090.005, 0.25);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.06] were positively associated with ESP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings revealed that cumulative exposure to etiological factors over the lifespan impacts normal breast tissue composition metrics, individually or jointly, to alter their dynamic equilibrium, with potential implications for breast cancer susceptibility and tumor etiologic heterogeneity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-023-01692-7","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T03:01:53Z","timestamp":1692068513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast"],"prefix":"10.1186","volume":"25","author":[{"given":"Mustapha","family":"Abubakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karun","family":"Mutreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maire A.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Gierach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"issue":"1","key":"1692_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"MJ Bissell","year":"2001","unstructured":"Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer. 2001;1(1):46\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1692_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2009.10.003","volume":"21","author":"LM Arendt","year":"2010","unstructured":"Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C. Stroma in breast development and disease. Semin Cell Dev Biol. 2010;21(1):11\u20138.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"1692_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/bcr2578","volume":"12","author":"J McCready","year":"2010","unstructured":"McCready J, Arendt LM, Rudnick JA, Kuperwasser C. The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res. 2010;12(3):205.","journal-title":"Breast Cancer Res"},{"issue":"7","key":"1692_CR4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41379-018-0033-7","volume":"31","author":"L Chollet-Hinton","year":"2018","unstructured":"Chollet-Hinton L, Puvanesarajah S, Sandhu R, Kirk EL, Midkiff BR, Ghosh K, et al. Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast. Mod Pathol. 2018;31(7):1085\u201396.","journal-title":"Mod Pathol"},{"issue":"7","key":"1692_CR5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","volume":"4","author":"PG Morris","year":"2011","unstructured":"Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res. 2011;4(7):1021\u20139.","journal-title":"Cancer Prev Res"},{"issue":"3","key":"1692_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jncics\/pkab015","volume":"5","author":"M Abubakar","year":"2021","unstructured":"Abubakar M, Fan S, Bowles EA, Widemann L, Duggan MA, Pfeiffer RM, et al. Relation of quantitative histologic and radiologic breast tissue composition metrics with invasive breast cancer risk. JNCI Cancer Spectr. 2021;5(3):66.","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"1692_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jncics\/pkaa119","volume":"5","author":"AD Vellal","year":"2021","unstructured":"Vellal AD, Sirinukunwattan K, Kensler KH, Baker GM, Stancu AL, Pyle ME, et al. Deep learning image analysis of benign breast disease to identify subsequent risk of breast cancer. JNCI Cancer Spectr. 2021;5(1):66.","journal-title":"JNCI Cancer Spectr"},{"key":"1692_CR8","unstructured":"Vorrherr H. The breast: morphology, physiology, and lactation. New York: NY Academic Press; 1974."},{"issue":"10","key":"1692_CR9","first-page":"873","volume":"8","author":"DM Gertig","year":"1999","unstructured":"Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL, et al. Association of age and reproductive factors with benign breast tissue composition1. Cancer Epidemiol Biomark Prev. 1999;8(10):873\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"1692_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10549-018-4768-0","volume":"170","author":"M Gabrielson","year":"2018","unstructured":"Gabrielson M, Chiesa F, Behmer C, R\u00f6nnow K, Czene K, Hall P. Association of reproductive history with breast tissue characteristics and receptor status in the normal breast. Breast Cancer Res Treat. 2018;170(3):487\u201397.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1692_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13058-021-01447-2","volume":"23","author":"L Yaghjyan","year":"2021","unstructured":"Yaghjyan L, Austin-Datta RJ, Oh H, Heng YJ, Vellal AD, Sirinukunwattana K, et al. Associations of reproductive breast cancer risk factors with breast tissue composition. Breast Cancer Res. 2021;23(1):70.","journal-title":"Breast Cancer Res"},{"issue":"35","key":"1692_CR12","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1200\/JCO.2008.21.5079","volume":"27","author":"KP McKian","year":"2009","unstructured":"McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, et al. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009;27(35):5893\u20138.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1692_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/dju286","volume":"106","author":"JD Figueroa","year":"2014","unstructured":"Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, et al. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst. 2014;106(10):66.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1692_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-016-3908-7","volume":"159","author":"JD Figueroa","year":"2016","unstructured":"Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, et al. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case\u2013control study. Breast Cancer Res Treat. 2016;159(1):163\u201372.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1692_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-15-0282","volume":"9","author":"GL Gierach","year":"2016","unstructured":"Gierach GL, Patel DA, Pfeiffer RM, Figueroa JD, Linville L, Papathomas D, et al. Relationship of terminal duct lobular unit involution of the breast with area and volume mammographic densities. Cancer Prev Res. 2016;9(2):149\u201358.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"1692_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0344-0338(80)80248-2","volume":"166","author":"S Wellings","year":"1980","unstructured":"Wellings S. A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol Res Pract. 1980;166(4):515\u201335.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"1692_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-011-1746-1","volume":"133","author":"AC Degnim","year":"2012","unstructured":"Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, et al. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat. 2012;133(1):169\u201377.","journal-title":"Breast Cancer Res Treat"},{"key":"1692_CR18","doi-asserted-by":"crossref","unstructured":"Sherman ME, Figueroa JD, Henry JE, Clare SE, Rufenbarger C, Storniolo AM. The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the \u201cMolecular Histology\u201d of the breast. Cancer Prev Res. 2012;5(4):528\u201335.","DOI":"10.1158\/1940-6207.CAPR-11-0234"},{"issue":"2","key":"1692_CR19","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/bcr3627","volume":"16","author":"I Pardo","year":"2014","unstructured":"Pardo I, Lillemoe HA, Blosser RJ, Choi M, Sauder CAM, Doxey DK, et al. Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank. Breast Cancer Res. 2014;16(2):R26.","journal-title":"Breast Cancer Res"},{"key":"1692_CR20","doi-asserted-by":"crossref","unstructured":"de Waard F, Halewijn EAB-V, Huizinga J. The bimodal age distribution of patients with mammary carcinoma. Evidence for the existence of 2 types of human breast cancer. Cancer. 1964;17(2):141\u201351.","DOI":"10.1002\/1097-0142(196402)17:2<141::AID-CNCR2820170202>3.0.CO;2-Z"},{"issue":"3","key":"1692_CR21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/bjc.1960.47","volume":"14","author":"F de Waard","year":"1960","unstructured":"de Waard F, de Laive JWJ, Baanders-van Halewijn EA. On the bimodal age distribution of mammary carcinoma. Br J Cancer. 1960;14(3):437\u201348.","journal-title":"Br J Cancer"},{"issue":"18","key":"1692_CR22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1200\/jco.2006.24.18_suppl.595","volume":"24","author":"WF Anderson","year":"2006","unstructured":"Anderson WF, Pfeiffer RM, Dores GM, Sherman ME. Bimodal breast cancer incidence patterns provide support for a dualistic model of mammary carcinogenesis. J Clin Oncol. 2006;24(18):595.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1692_CR23","first-page":"9","volume":"64","author":"KG Manton","year":"1980","unstructured":"Manton KG, Stallard E. A two-disease model of female breast cancer: mortality in 1969 among white females in the United States. J Natl Cancer Inst. 1980;64(1):9\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"1692_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-94-011-0489-0_5","volume-title":"Reducing breast cancer risk in women","author":"M Ewertz","year":"1995","unstructured":"Ewertz M. Risk from Age, Race and Social Class. In: Stoll BA, editor. Reducing breast cancer risk in women. Dordrecht: Springer, Netherlands; 1995. p. 41\u20135."},{"issue":"1","key":"1692_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2407-6-78","volume":"6","author":"C Bouchardy","year":"2006","unstructured":"Bouchardy C, Morabia A, Verkooijen HM, Fioretta G, Wespi Y, Sch\u00e4fer P. Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy. BMC Cancer. 2006;6(1):78.","journal-title":"BMC Cancer"},{"issue":"8","key":"1692_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/dju165","volume":"106","author":"WF Anderson","year":"2014","unstructured":"Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106(8):66.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1692_CR27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10552-007-9057-x","volume":"18","author":"WF Anderson","year":"2007","unstructured":"Anderson WF, Chen BE, Brinton LA, Devesa SS. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control. 2007;18(10):1187\u201398.","journal-title":"Cancer Causes Control"},{"key":"1692_CR28","doi-asserted-by":"crossref","unstructured":"Albrektsen G, Heuch I, Tretli S, Kv, X, Le G. Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million norwegian women. Epidemiology. 1994;5(6):604\u201311.","DOI":"10.1097\/00001648-199411000-00008"},{"issue":"2","key":"1692_CR29","first-page":"211","volume":"68","author":"JH Lubin","year":"1982","unstructured":"Lubin JH, Burns PE, Blot WJ, Lees AW, May C, Morris LE, et al. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J Natl Cancer Inst. 1982;68(2):211\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1692_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.2910370105","volume":"37","author":"DR Pathak","year":"1986","unstructured":"Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ. Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer. 1986;37(1):21\u20135.","journal-title":"Int J Cancer"},{"key":"1692_CR31","doi-asserted-by":"crossref","unstructured":"Breast Cancer Risk After Recent Childbirth. Ann Intern Med. 2019;170(1):22\u201330.","DOI":"10.7326\/P18-0020"},{"issue":"4","key":"1692_CR32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc1839","volume":"6","author":"P Schedin","year":"2006","unstructured":"Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer. 2006;6(4):281\u201391.","journal-title":"Nat Rev Cancer"},{"key":"1692_CR33","doi-asserted-by":"crossref","unstructured":"Schonfeld SJ, Pfeiffer RM, Lacey JV, Jr., Berrington de Gonz\u00e1lez A, Doody MM, Greenlee RT, et al. Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: an aggregated study. Am J Epidemiol. 2011;173(5):509\u201317.","DOI":"10.1093\/aje\/kwq404"},{"issue":"10","key":"1692_CR34","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","volume":"13","author":"MD Althuis","year":"2004","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev. 2004;13(10):1558\u201368.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"1692_CR35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250\u201363.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1692_CR36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10911-009-9119-7","volume":"14","author":"TR Lyons","year":"2009","unstructured":"Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia. 2009;14(2):12.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"1692_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10549-019-05442-2","volume":"179","author":"EH Allott","year":"2020","unstructured":"Allott EH, Shan Y, Chen M, Sun X, Garcia-Recio S, Kirk EL, et al. Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications. Breast Cancer Res Treat. 2020;179(1):185\u201395.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1692_CR38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10549-012-2365-1","volume":"137","author":"CI Li","year":"2013","unstructured":"Li CI, Beaber EF, Tang M-TC, Porter PL, Daling JR, Malone KE. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20\u201344 years of age. Breast Cancer Res Treat. 2013;137(2):579\u201387.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1692_CR39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9632-6","volume":"109","author":"RC Millikan","year":"2008","unstructured":"Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith LV, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109(1):123\u201339.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1692_CR40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/bjc.2013.807","volume":"110","author":"ME Work","year":"2014","unstructured":"Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, et al. Reproductive risk factors and oestrogen\/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer. 2014;110(5):1367\u201377.","journal-title":"Br J Cancer"},{"issue":"12","key":"1692_CR41","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1055-9965.EPI-06-0489","volume":"15","author":"LU Rosenberg","year":"2006","unstructured":"Rosenberg LU, Einarsd\u00f3ttir K, Friman EI, Wedr\u00e9n S, Dickman PW, Hall P, et al. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomark Prev. 2006;15(12):2482\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"1692_CR42","first-page":"1","volume":"8","author":"H Ma","year":"2006","unstructured":"Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8(4):1\u201311.","journal-title":"Breast Cancer Res"},{"key":"1692_CR43","first-page":"66","volume":"6","author":"A Mustapha","year":"2022","unstructured":"Mustapha A, Jenny C-C, Raza AH, Nilanjan C, Penny C, Frances D, et al. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. Int J Cancer. 2022;6:66.","journal-title":"Int J Cancer"},{"issue":"9","key":"1692_CR44","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1210\/me.2002-0073","volume":"16","author":"CM D\u2019Cruz","year":"2002","unstructured":"D\u2019Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, et al. Persistent parity-induced changes in growth factors, TGF-\u03b23, and differentiation in the rodent mammary gland. Mol Endocrinol. 2002;16(9):2034\u201351.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"1692_CR45","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2353\/ajpath.2006.050677","volume":"168","author":"SM McDaniel","year":"2006","unstructured":"McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol. 2006;168(2):608\u201320.","journal-title":"Am J Pathol"},{"issue":"1","key":"1692_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molmed.2008.11.001","volume":"15","author":"L R\u00f8nnov-Jessen","year":"2009","unstructured":"R\u00f8nnov-Jessen L, Bissell MJ. Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med. 2009;15(1):5\u201313.","journal-title":"Trends Mol Med"},{"issue":"1","key":"1692_CR47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.1996.76.1.69","volume":"76","author":"L Ronnov-Jessen","year":"1996","unstructured":"Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996;76(1):69\u2013125.","journal-title":"Physiol Rev"},{"key":"1692_CR48","doi-asserted-by":"crossref","unstructured":"Palmer JR, Viscidi E, Troester MA, Hong C-C, Schedin P, Bethea TN, et al. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER consortium. J Natl Cancer Inst. 2014;106(10):66.","DOI":"10.1093\/jnci\/dju237"},{"issue":"9","key":"1692_CR49","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/1055-9965.EPI-11-0465","volume":"20","author":"JR Palmer","year":"2011","unstructured":"Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L. Parity and lactation in relation to estrogen receptor negative breast cancer in African American Women. Cancer Epidemiol Biomark Prev. 2011;20(9):1883\u201391.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1692_CR50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3181\/00379727-216-44153B","volume":"216","author":"MP Cleary","year":"1997","unstructured":"Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997;216(1):28\u201343.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1692_CR51","doi-asserted-by":"crossref","unstructured":"Group TPBCC. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4(11):e181771-e.","DOI":"10.1001\/jamaoncol.2018.1771"},{"key":"1692_CR52","doi-asserted-by":"crossref","unstructured":"Group EHBCC. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218\u201326.","DOI":"10.1093\/jnci\/djg022"},{"issue":"24","key":"1692_CR53","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/jnci\/djn411","volume":"100","author":"WF Anderson","year":"2008","unstructured":"Anderson WF, Rosenberg PS, Menashe I, Mitani A, Pfeiffer RM. Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst. 2008;100(24):1804\u201314.","journal-title":"J Natl Cancer Inst."},{"issue":"10","key":"1692_CR54","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/jnci\/djac063","volume":"114","author":"H Sung","year":"2022","unstructured":"Sung H, Koka H, Marino N, Pfeiffer RM, Cora R, Figueroa JD, et al. Association of genetic ancestry with terminal duct lobular unit involution among healthy women. J Natl Cancer Inst. 2022;114(10):1420\u20134.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1692_CR55","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr3170","volume":"14","author":"XR Yang","year":"2012","unstructured":"Yang XR, Figueroa JD, Falk RT, Zhang H, Pfeiffer RM, Hewitt SM, et al. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res. 2012;14(2):R64.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1692_CR56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-017-0850-5","volume":"19","author":"C Guo","year":"2017","unstructured":"Guo C, Sung H, Zheng S, Guida J, Li E, Li J, et al. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors. Breast Cancer Res. 2017;19(1):61.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1692_CR57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41523-020-00184-7","volume":"6","author":"C Bodelon","year":"2020","unstructured":"Bodelon C, Oh H, Derkach A, Sampson JN, Sprague BL, Vacek P, et al. Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast. npj Breast Cancer. 2020;6(1):41.","journal-title":"npj Breast Cancer"},{"issue":"3","key":"1692_CR58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0029-7844(97)00295-0","volume":"90","author":"F Parazzini","year":"1997","unstructured":"Parazzini F, Braga C, La Vecchia C, Negri E, Acerboni S, Franceschi S. Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Obstet Gynecol. 1997;90(3):453\u20136.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"1692_CR59","first-page":"783","volume":"7","author":"L Titus-Ernstoff","year":"1998","unstructured":"Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, et al. Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomark Prev. 1998;7(9):783\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"1692_CR60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-020-05744-w","volume":"182","author":"S Azam","year":"2020","unstructured":"Azam S, Jacobsen KK, Aro AR, Lynge E, Andersen ZJ. Hormone replacement therapy and mammographic density: a systematic literature review. Breast Cancer Res Treat. 2020;182(3):555\u201379.","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"1692_CR61","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women\u2019s health initiative randomized trial. JAMA. 2003;289(24):3243\u201353.","journal-title":"JAMA"},{"key":"1692_CR62","doi-asserted-by":"crossref","unstructured":"Million Women Study C. Breast cancer and hormone-replacement therapy in the Million Women Study. The Lancet. 2003;362(9382):419\u201327.","DOI":"10.1016\/S0140-6736(03)14065-2"},{"key":"1692_CR63","doi-asserted-by":"crossref","unstructured":"Garcia-Closas M, Brinton L, Lissowska J, Chatterjee N, Peplonska B, WF Anderson N. Established breast cancer risk factors by clinically important tumour characteristics. British journal of cancer. 2006;95(1):123\u20139.","DOI":"10.1038\/sj.bjc.6603207"},{"issue":"12","key":"1692_CR64","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.10984","volume":"95","author":"JR Daling","year":"2002","unstructured":"Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer. 2002;95(12):2455\u201364.","journal-title":"Cancer"},{"key":"1692_CR65","doi-asserted-by":"crossref","unstructured":"Li CI, Malone KE, Porter PL, Weiss NS, Tang M-TC, Cushing-Haugen KL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA. 2003;289(24):3254\u201363.","DOI":"10.1001\/jama.289.24.3254"},{"issue":"11","key":"1692_CR66","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1470-2045(06)70911-1","volume":"7","author":"GK Reeves","year":"2006","unstructured":"Reeves GK, Beral V, Green J, Gathani T, Bull D. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 2006;7(11):910\u20138.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1692_CR67","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.23655","volume":"123","author":"D Flesch-Janys","year":"2008","unstructured":"Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008;123(4):933\u201341.","journal-title":"Int J Cancer"},{"issue":"5","key":"1692_CR68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/ijc.29861","volume":"138","author":"KA Hirko","year":"2016","unstructured":"Hirko KA, Chen WY, Willett WC, Rosner BA, Hankinson SE, Beck AH, et al. Alcohol consumption and risk of breast cancer by molecular subtype: prospective analysis of the nurses\u2019 health study after 26 years of follow-up. Int J Cancer. 2016;138(5):1094\u2013101.","journal-title":"Int J Cancer"},{"issue":"4","key":"1692_CR69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12672-017-0297-2","volume":"8","author":"ML Baglia","year":"2017","unstructured":"Baglia ML, Malone KE, Tang M-TC, Li CI. Alcohol intake and risk of breast cancer by histologic subtype and estrogen receptor status among women aged 55 to 74 years. Hormones Cancer. 2017;8(4):211\u20138.","journal-title":"Hormones Cancer"},{"issue":"2","key":"1692_CR70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/126.2.319","volume":"126","author":"GA Colditz","year":"1987","unstructured":"Colditz GA, Stampfer MJ, Willett WC, Stason WB, Rosner B, Hennekens CH, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol. 1987;126(2):319\u201325.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1692_CR71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/0284186X.2017.1404635","volume":"57","author":"A Augustinsson","year":"2018","unstructured":"Augustinsson A, Ellberg C, Kristoffersson U, Borg \u00c5, Olsson H. Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer. Acta Oncol. 2018;57(5):595\u2013603.","journal-title":"Acta Oncol"},{"issue":"3","key":"1692_CR72","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/gme.0b013e31818ffe28","volume":"16","author":"AI Phipps","year":"2009","unstructured":"Phipps AI, Buist DSM. Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause. 2009;16(3):576\u201381.","journal-title":"Menopause"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-023-01692-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T15:07:03Z","timestamp":1700233623000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-023-01692-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1186\/s13058-023-01692-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2883575\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by institutional review boards at the National Institutes of Health (NIH, Institutional Review Board of the National Cancer Institute).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}